Vitamin d study aims to boost quality of life for IBD patients

NCT ID NCT07177157

Not yet recruiting Knowledge-focused Sponsor: Terry Ponich Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether taking a daily vitamin D supplement (2000 IU) for 12 months can improve the health and quality of life of people with Crohn's disease or ulcerative colitis. Researchers will track how well participants stick to the supplement and measure their vitamin D levels, disease activity, and overall well-being. The study involves 150 adults from two hospitals in Canada.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Vitamin D3 (cholecalciferol) 2000 IU daily
What this could lead to: If successful, this could show that a simple daily vitamin D supplement helps improve quality of life for people with inflammatory bowel disease.
What could go wrong: This is an early-phase study focused on adherence and feasibility, not on proving that vitamin D treats the disease. The results may not lead to a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN DISEASE (CD) IBD (INFLAMMATORY BOWEL DISEASE) ULCERATIVE COLITIS (UC)

Contacts and locations

Locations

Victoria Hospital - London Health Sciences Centre

London, Ontario, N6A 5A5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.